|
|
Post by letitride on May 7, 2024 14:31:08 GMT -5
I got in at $13
|
|
|
|
Post by dh4mizzou on May 7, 2024 14:43:19 GMT -5
Since we're airing our dirty laundry ;-) My Cost Basis is a hair under $ 6.00 POST SPLIT
|
|
|
|
Post by cretin11 on May 7, 2024 15:05:29 GMT -5
My basis is under a dollar! (That’s pre-split based, but it just reads so much better as being “under a dollar”)
|
|
|
|
Post by ktim on May 7, 2024 15:08:16 GMT -5
When does it stop being "hopium" and become reasonable optimism? At some point "hopium" is insulting. I'd say one indicator is people giving share price predictions without any hint of a rationale. Seems as if share price numbers picked out of thin air are more "hope" than "analysis". Especially true when predictions are for a market cap of ~$35B. I'm optimistic. |
|
|
|
Post by parrerob on May 7, 2024 15:11:05 GMT -5
I started pre adcom with 20.... added more before approval (Afrezza) at around 30.... added again the day of approval at 50.... then I started using "hopium" just looking at the disaster. During Covid I doubled my "hopium" dose and got all in at around 1... now I am green with a 3 cost basis and a lot of shares....
Having been in and out with many other bio company (omer acad eagle p. and many other) but mnkd is the only one I only bought and never sold...big mistake. it was wrong in the past.... hope it will be a good move in the future....
Up to me Here We still need hopium for another 6 months... then switch to adrenaline (:-)
|
|
|
|
Post by prcgorman2 on May 7, 2024 15:11:21 GMT -5
My basis is under a dollar! (That’s pre-split based, but it just reads so much better as being “under a dollar”) Ooh, still here but didn't DCA? Well, no matter, you're still coming up on green. We're pulling for you! |
|
|
|
Post by ktim on May 7, 2024 15:20:57 GMT -5
When does it stop being "hopium" and become reasonable optimism? At some point "hopium" is insulting. For me Im glad to say it was back between .80 and a dollar when I went all In. Covid gave a lot of amazing buying opportunities and MNKD was certainly one of them. It was well after UTHR partnership deal, so MNKD was considerably derisked at that point and yet it got slammed with the market sell off because it was a small, volatile, risk-on stock in a horrendous risk-off market correction. I had the phenomenal luck of wanting to sell much of my under water shares at the end of 2019 to offset capital gains that year. Figured I could wait for wash sale period before repurchasing them, and then lucked into getting them back much cheaper (and lots of extra shares). I think back then it was very reasonable to assume MNKD shares would recover... presuming one had confidence the entire world economic system didn't come to an end. |
|
|
|
Post by runner on May 7, 2024 16:51:02 GMT -5
I’ve been in this since 2007. I bought a boatload at that time but I have now averaged down to $7.48 per share.
|
|
|
|
Post by BD on May 7, 2024 17:28:40 GMT -5
I have a fear (among others of course). I haven't really been conscious of this fear until fairly recently, or if I have then I must have swept it under the mental rug.
The fear is that MNKD never really "makes it" and just fizzles out over the next ten years.
NOTE: This is not a prediction!! It's a fear! So please keep that in mind.
But that's really not the whole fear, because I've now really limited the damage I can do to my family's finances by getting over-exuberant about MNKD.
The actual fear is that this board, being of the quality that it is, would have contributed to many more shareholders holding their positions a lot longer than they might've otherwise.
I fear this because it has happened to me. A board I was moderating (not when I was an admin) was a lot of fun, but the stock we were there to discuss was a total Pink Sheet disaster of a scam. Just horrific. And they sponsored drag racing cars and motorcycles.
I hate the idea of a board I've put so much of my time into ending up just encouraging members to throw good money after bad. I know a few of you are actually up, and that brings me joy, but MNKD really needs to give more of us an opportunity to exit with a nice profit before I stop fretting about this.
Just sayin'.
|
|
|
|
Post by cretin11 on May 7, 2024 18:04:44 GMT -5
BD from my perspective you have not prompted anyone to buy more MNKD, at least nowhere near as much as numerous others here. You aren’t a pumper and have no need for any feelings of guilt there.
And prcgorman I’m shocked at your lack of math skills if you think I haven’t DCA’d on this thing! LOL, I have massively DCA’d not to mention all the premiums from selling calls and puts. But you gotta use those techniques to lower cost basis when you’ve saddled yourself with $50+ shares. It wasn’t easy getting my basis down to under $1 pre-reverse split cost (aka under $5 post RS).
|
|
|
|
Post by cretin11 on May 7, 2024 18:14:41 GMT -5
When does it stop being "hopium" and become reasonable optimism? At some point "hopium" is insulting. I'd say one indicator is people giving share price predictions without any hint of a rationale. Seems as if share price numbers picked out of thin air are more "hope" than "analysis". Especially true when predictions are for a market cap of ~$35B. Well said. “$50 in 5 years” for example. Some of the “rationale” given can also fall into the hopium category. |
|
|
|
Post by sayhey24 on May 7, 2024 18:17:59 GMT -5
BD - MNKD has the greatest advance in diabetes care since Banting and Best. They also have Tyvaso DPI paying the bills. If MNKD does not make it big its not your fault, its Mikes.
If Inhale-2 actually showed 1.5-2% A1c reduction, thats a huge deal. We never heard the results, maybe tomorrow we will. If the results were not that great then we have the kids approval coming next year.
In the mean time Mike can get the pps at least to $10 by getting Saxenda DPI to P2 trials. Of course first we need to do P1 trials.
|
|
|
|
Post by prcgorman2 on May 7, 2024 20:24:22 GMT -5
I'd say one indicator is people giving share price predictions without any hint of a rationale. Seems as if share price numbers picked out of thin air are more "hope" than "analysis". Especially true when predictions are for a market cap of ~$35B. Well said. “$50 in 5 years” for example. Some of the “rationale” given can also fall into the hopium category. It is a fair criticism that I did not offer a rationale for my $50/share in 5 years. What I was thinking of is what I normally talk about which is Earnings Per Share multiplied by Price-to-Earnings Ratio. To get over $50/share, and assuming a conservative P/E of 17, MannKind would need an EPS of $2.97/share on ~270M shares which implies ~$802M in profit. NYU, however, estimates the current (Jan 2024) P/E for drugs (pharmaceutical) is 38.84 which reduces the EPS required to $1.29 per share (or $346M in profit). pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/pedata.htmlIf I remember correctly, the revenue projection on Clofazimine alone was over $1B, so $50/share in 5 years doesn’t feel like hopium. It feels like something reasonable to hope for. |
|
|
|
Post by cretin11 on May 7, 2024 20:32:08 GMT -5
Ah yes, there’s Gandalf’s quote again…
|
|
|
|
Post by ktim on May 7, 2024 20:37:02 GMT -5
Just imagine if we mixed Saxenda (whatever that is), Bluhale, THC and a Covid vaccine. Let's just forget about the pipeline actually being developed. Our future obviously is dependent on things not in the pipeline.
Or... we could look at the plans management has in place... which will almost certainly result in very impressive share gains in next few years if executed as planned... and judge them against that.
|
|
